“Sensory Neuroimmune Signaling Opens a New Precision Medicine Window for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis”. Novera 1, no. 1 (April 22, 2026). Accessed April 22, 2026. https://submit.noverapress.com/index.php/Novera/article/view/10.